Histological classification of liver and intrahepatic bile duct cancers in SEER registries
Explore this paper's citation graph
Summary
A classification system based on abstracted information on histologies of liver and intrahepatic bile duct cancers diagnosed during 1978–2007 within all Surveillance, Epidemiology, and End Results (SEER) registries may facilitate studies of primary liver cancers.
- Type
- article
- Published
- 2011-01-01
- Cited by
- 111
- References
- 11
- Access
- Open access
- OpenAlex
- https://openalex.org/W8872191
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:23664353
Keywords
Medicine, Intrahepatic Cholangiocarcinoma, Hepatocellular carcinoma, Bile duct, Intrahepatic bile ducts
References
- Pathology and genetics of tumours of the digestive system
- International Classification of Diseases for Oncology
- Current approach to hepatocellular carcinoma.
- Liver, gallbladder, extrahepatic bile ducts, and pancreas
- Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis.
- Discerning Tumor Status from Unstructured MRI Reports—Completeness of Information in Existing Reports and Utility of Automated Natural Language Processing
- Cholangiocarcinoma—controversies and challenges
- Outcomes from Combined Chemoradiotherapy in Unresectable and Locally Advanced Resected Cholangiocarcinoma
- Management of hepatocellular carcinoma: An update
- Protocol for the examination of specimens from patients with carcinoma of the intrahepatic bile ducts.
Cited by
- The Risk of Hepatocellular Carcinoma Among Individuals With Acquired Immunodeficiency Syndrome in the United States
- NSAID use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The Liver Cancer Pooling Project
- Future of Hepatocellular Carcinoma Incidence in the United States Forecast Through 2030.
- Qualitative Improvement Methods Through Analysis of Inquiry Contents for Cancer Registration
- Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
- Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based study in SEER-Medicare
- Critical evaluation of the American Joint Commission on Cancer (AJCC) 8th edition staging system for patients with Hepatocellular Carcinoma (HCC): A Surveillance, Epidemiology, End Results (SEER) analysis
- Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The Liver Cancer Pooling Project
- Fibrosis score impacts survival following resection for hepatocellular carcinoma (HCC): A Surveillance, End Results and Epidemiology (SEER) database analysis.
- Cancer-site-specific disparities in New York, including the 1945–1965 birth cohort’s impact on liver cancer patterns
- Body Mass Index, Diabetes and Intrahepatic Cholangiocarcinoma Risk: The Liver Cancer Pooling Project and Meta-analysis
- Precision surgery for primary liver cancer
- Prediagnostic levels of urinary 8-epi-prostaglandin F2α and prostaglandin E2 metabolite, biomarkers of oxidative damage and inflammation, and risk of hepatocellular carcinoma.
- Biliary Tract Cancer Incidence and Trends in the United States by Demographic Group, 1999–2013
- Changing Epidemiology of HCC: How to Screen and Identify Patients at Risk?
- The Combination of Stereotactic Body Radiation Therapy and Immunotherapy in Primary Liver Tumors
- Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib
- Cancers attributable to infections in Canada.
- Urinary Metabolites Diagnostic and Prognostic of Intrahepatic Cholangiocarcinoma
- p66Shc promotes HCC progression in the tumor microenvironment via STAT3 signaling.
Related papers
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- Future of Hepatocellular Carcinoma Incidence in the United States Forecast Through 2030.
- Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
- Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise
- Biliary Tract Cancer Incidence and Trends in the United States by Demographic Group, 1999–2013
- International trends in liver cancer incidence, overall and by histologic subtype, 1978–2007
- Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.
- Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
- Population attributable fractions of risk factors for hepatocellular carcinoma in the United States
- Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.